SEMPRA - EQUITY AND EARNINGS PER COMMON SHARE (Tables)

9 Months Ended

Sep. 30, 2024

Earnings Per Share [Abstract]

Schedule of Other Ownership Interests

The following table summarizes net income attributable to Sempra and transfers (to) from NCI, which shows the effects of changes in Sempra’s ownership interest in its subsidiaries on Sempra’s shareholders’ equity.

NET INCOME ATTRIBUTABLE TO SEMPRA AND TRANSFERS (TO) FROM NCI
(Dollars in millions)
	Three months ended		Nine months ended
	September 30, 2023
Sempra:
Net income attributable to Sempra	$	732	$	2,327
Transfers (to) from NCI:
Decrease in shareholders’ equity for sales of NCI	(62)		(44)
Net transfers (to) from NCI	(62)		(44)
Change from net income attributable to Sempra and transfers (to) from NCI	$	670	$	2,283

Schedule of Earnings Per Share, Basic and Diluted

EARNINGS PER COMMON SHARE COMPUTATIONS
(Dollars in millions, except per share amounts; shares in thousands)
	Three months ended September 30,				Nine months ended September 30,
	2024		2023		2024		2023
Sempra:
Numerator:
Earnings attributable to common shares	$	638	$	721	$	2,152	$	2,293
Denominator:
Weighted-average common shares outstanding for basic EPS(1)	633,752		630,036		633,342		629,963
Dilutive effect of common shares sold forward	2,312		—		1,375		—
Dilutive effect of stock options and RSUs(2)	1,997		2,288		1,849		2,268
Weighted-average common shares outstanding for diluted EPS	638,061		632,324		636,566		632,231
EPS:
Basic	$	1.01	$	1.14	$	3.40	$	3.64
Diluted	$	1.00	$	1.14	$	3.38	$	3.63

(1)    Includes 615 and 716 fully vested RSUs held in our Deferred Compensation Plan for the three months ended September 30, 2024 and 2023, respectively, and 616 and 716 of such RSUs for the nine months ended September 30, 2024 and 2023, respectively. These fully vested RSUs are included in weighted-average common shares outstanding for basic EPS because there are no conditions under which the corresponding shares will not be issued.

(2)    Due to market fluctuations of both Sempra common stock and the comparative indices used to determine the vesting percentage of our total shareholder return performance-based RSUs, which we discuss in Note 10 of the Notes to Consolidated Financial Statements in the Annual Report, dilutive RSUs may vary widely from period-to-period.